Learn more
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
African Vaccine Manufacturing Accelerator (AVMA)
COVID-19
#FOROURFUTURE
Five years to save 8 million lives: everything you need to know about Gavi’s Investment Opportunity
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
SPOTLIGHT ON MEASLES
KEY PUBLICATION
Investment Opportunity 2026–2030Download
LATEST
Progress report
News releases
Communication toolkits
New study published in Health Affairs journal shows immunisation will save 24 million people from falling into the poverty trap because of healthcare costs.
07 February 2018